Wellington Management

AssetWatch specializes in proactive predictive maintenance solutions. It offers a rapidly deployable remote condition monitoring service featuring wireless sensors, communication hubs, advanced software, and expert analysis. The company combines predictive analytics with expert insights to provide actionable recommendations, helping global manufacturers minimize unplanned downtime and transition from reactive to proactive maintenance.

Maza is a mobile application offering digital banking services and financial products. It provides users with access to savings accounts, NFC-enabled prepaid cards for online or offline purchases, bill payments, and money transfers, aiming to deliver a seamless and cost-effective banking experience.

Atsena Therapeutics is a clinical-stage company focused on developing gene therapies for inherited retinal diseases. Utilizing an adeno-associated virus (AAV) platform, including a novel spreading capsid, Atsena's clinical programs aim to prevent blindness caused by genetic mutations.

Lumafield provides industrial computed tomography solutions for non-destructive testing and inspection in engineering environments. Its Neptune X-ray CT scanner enables detailed imaging to analyze internal structures and detect defects across materials. The Voyager software platform delivers cloud-based AI-powered analysis, automated inspections, and collaboration tools to support product development from design through manufacturing. Triton is a high-speed CT system designed for rapid scanning in high-volume manufacturing settings. The company serves industries including aerospace, automotive, electronics, and medical devices, helping to improve product quality and reliability through advanced imaging and analysis capabilities.

Just Salad is a fast-casual restaurant chain specializing in healthy, affordable meals. It offers salads, wraps, smoothies, soups, and other nutritious options. The company prioritizes sustainability through initiatives like its Reusable Bowl Program, carbon-labeled menus, compostable packaging, and recycling programs.

MedinCell S.A. is a pharmaceutical company focused on developing innovative therapeutic solutions through its proprietary BEPO technology, which facilitates long-acting injectable products utilizing biodegradable polymers and a biocompatible solvent. Based in Jacou, France, the company is engaged in ongoing research and development to optimize the efficiency and accessibility of medical treatments across various therapeutic areas. MedinCell's product pipeline includes several candidates, such as mdc-IRM, a subcutaneous injection for schizophrenia currently in Phase III trials, and mdc-CWM, an intra-articular injection aimed at treating pain and inflammation. Additionally, the company is exploring formulations like mdc-WWM for contraception and mdc-ANG for central nervous system disorders, alongside other candidates targeting pain management and organ transplant applications. Through its advancements in controlled, long-acting injectables, MedinCell aims to enhance treatment outcomes for patients.

Tabby offers flexible payment solutions for online shopping. Based in the United Arab Emirates, it enables users to pay for purchases in deferred single payments or installments.

Swanston Labs builds data-driven solutions aimed at disrupting the convergence of media, entertainment, technology, and commerce. The company focuses on leveraging innovative technologies to address the $7 trillion global leisure spending market. Swanston Labs operates under the Swanston Organization, which also includes Swanston Family Ventures and Swanston Philanthropy, collectively advancing the mission of innovation and inclusion.

Helicore Biopharma is a biopharmaceutical company dedicated to developing innovative treatments for obesity and related metabolic disorders. Its portfolio includes novel therapeutics based on glucose-dependent insulinotropic peptide (GIP) antagonism and monoclonal antibodies that bind circulating GIP ligands, forming a modular platform for anti-obesity medicines. The company aims to help patients with obesity and related conditions achieve significant weight loss.

Genius Sports Group Limited, founded in 2000 and headquartered in London, is a leading provider of technology-driven solutions in the sports data and betting industries. Through its subsidiaries, the company offers a range of services, including sports data software for leagues and governing bodies, live betting products, and personalized marketing campaigns for the sports betting sector. Genius Sports has established itself as a trusted partner to numerous international sports organizations, including major federations and professional leagues. Its commitment to the integrity and commercialization of sports data is central to its operations, emphasizing collaboration between sports organizations and data users to ensure both protection and opportunity maximization. The company's offerings are categorized into three main areas: Sports Technology and Services, Betting Technology, and Media Technology, all supported by a robust proprietary data infrastructure. Genius Sports primarily generates revenue from its Betting Technology division and has a significant presence in the European market.

Thoras.ai is an AI cloud management platform..It helps to detection, monitor performance, and manage costs.

Saluda Medical is a medical device company specializing in closed-loop neuromodulation therapies for chronic neurological conditions. Founded in 2010 and headquartered in Australia, the company develops innovative devices like Evoke, designed to optimize neural stimulation based on real-time feedback.

SiteOne Therapeutics is a San Francisco-based company developing innovative therapeutics and diagnostics for acute and chronic pain. Their lead candidates are selective inhibitors of the Naᵥ1.7 ion channel, aiming to treat pain safely and effectively without relying on NSAIDs or opioids.

Databricks offers a unified data analytics platform that simplifies data integration, enables real-time experimentation, and facilitates robust deployment of production applications for developers and data scientists. Serving diverse industries worldwide, Databricks' platform supports collaborative data science, machine learning workflows, and integrates with various cloud services.

Current is a consumer fintech banking platform dedicated to enhancing financial access for everyday Americans. The company focuses on developing integrated solutions that address the barriers preventing individuals from achieving their financial goals. By simplifying banking processes and providing user-friendly tools, Current aims to empower users to build a secure financial future. With backing from prominent investors, Current continues to innovate in the financial technology space, striving to meet the diverse needs of its customer base through modern banking solutions.

Archer develops and operates all-electric vertical takeoff and landing aircraft, aiming to enhance urban mobility sustainably. Its four-passenger aircraft can travel up to 60 miles at speeds reaching 150 mph with minimal noise.

nChroma Bio is a biotechnology company specializing in targeted genetic medicine. It operates an integrated product engine for safe, accurate, and targeted in vivo administration, aiming to overcome limitations of current genetic medicine techniques. The company focuses on liver-targeted therapies, initially for chronic hepatitis B and D, leveraging epigenetics to enable precise and specific gene regulation. This approach allows for therapies with programmable tissue specificity, potentially offering durable and targeted cures for the liver and other organs.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Olema Oncology is a preclinical biotechnology company dedicated to developing innovative therapies for the treatment and prevention of estrogen receptor-positive breast cancer. The company specializes in discovering and commercializing targeted treatments specifically designed for women's cancers. By leveraging its extensive understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance, Olema aims to create compounds that surpass existing therapies. The company's focus is on transforming the standard of care for both pre- and post-menopausal women with cancer, with an emphasis on developing more effective and convenient treatment options. Olema's pipeline includes drug candidates such as OP-1250 and OP-3136, which have progressed through discovery and preclinical studies.

Metsera is a clinical-stage biopharmaceutical company specializing in developing innovative therapies for obesity and metabolic conditions. It focuses on advancing oral and injectable treatments, integrating proprietary health technology tools for personalized care.

Beta Bionics is a medical device company focused on diabetes care, developing and commercializing the iLet Bionic Pancreas System. The iLet uses adaptive closed-loop algorithms to automate insulin delivery and glucose management for people with insulin-requiring diabetes, with configurations that support bihormonal approaches. The company designs, manufactures, and markets the system to the diabetes community, aiming to simplify treatment and improve health outcomes by reducing the burden of daily insulin dosing and monitoring. Through its single-segment business model, Beta Bionics centers on bringing the iLet from development to commercialization.

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines targeting verified biology to improve care for patients with solid tumors.

Founded in 2018, Crisp is a Brooklyn-based company that provides demand forecasting software for the food industry. It connects consumer packaged goods (CPG) companies to real-time point-of-sale and inventory data from over 40 retailers and distributors, delivering store-level insights through business intelligence tools.

Trace Machina is a technology company that develops and maintains open-source simulation infrastructure. It focuses on advanced technologies such as AI, robotics, and autonomous mobility to reduce simulation costs for safety-critical systems, making it more affordable for builders to create and test futuristic technologies using existing infrastructure and tools.

Mindset provides disability application assistance to individuals with mental illness or physical impairments, helping them obtain Social Security Disability benefits. The service offers guidance on applying for Social Security Disability Insurance, support for living expenses and medical bills, and continuous monitoring to facilitate the benefits process and ensure a smoother lifestyle for patients and their caregivers.

Abnormal Security Corporation is a San Francisco-based company that specializes in cloud-based email security solutions for Microsoft Office 365 and G Suite. Founded in 2018, the company provides a comprehensive platform designed to protect enterprises from targeted email attacks. Utilizing a data science approach, Abnormal Security offers features such as inbound email protection, detection of email account compromises, and response capabilities. Its technology includes Abnormal Behavior Technology, which models identities of both employees and external senders, profiles relationships, and analyzes email content to prevent threats like credential phishing, internal phishing, employee impersonation, and invoice fraud. The company primarily serves industries including financial services, healthcare, and oil, gas, and utilities, aiming to mitigate risks related to account takeovers and financial losses.

MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.

Day One Biopharmaceuticals is a clinical-stage biotechnology company focused on developing targeted therapies for genetically defined cancers across all ages, with an initial emphasis on pediatric patients. The company aims to bring effective cancer treatments to families by advancing therapies that can benefit both children and adults, prioritizing programs that can progress to the market rapidly. Day One pursues licensing or acquisition of promising products from research institutions and industry partners to expand its pipeline. Its lead candidate, DAY101, is an oral, brain-penetrant, highly selective type II pan-RAF kinase inhibitor designed to target cancers driven by the RAF signaling pathway. By applying insights from childhood cancer biology, the company seeks to address unmet needs in oncology and broaden access to precision therapies.

Founded in 2020 and headquartered in Boston, Massachusetts, Scorpion Therapeutics is a clinical-stage biotechnology company specializing in precision oncology. It develops targeted small-molecule drugs to treat cancer by focusing on three areas: therapies against known oncogenes, agents for currently undruggable targets, and drugs for new targets.

Element Biosciences develops innovative genetic analysis tools for research and diagnostic markets. Founded in 2017, the company specializes in a disruptive DNA sequencing technology that offers high-quality data, workflow flexibility, and affordable access to next-generation sequencing.

TS Conductor specializes in advanced electrical transmission conductors. Utilizing a carbon-fiber-composite core instead of steel, their products are lighter, stronger, and more efficient, carrying higher current with reduced energy loss.

Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, in Phase 2a development for nontuberculous mycobacteria, or NTM, lung infection, and in preparation for Phase 2a development in cystic fibrosis, or CF, affected individuals with chronic NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of persistent methicillin resistant staphylococcus aureus, or MRSA, lung infection in CF. Savara’s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. The most recent acquisition is aerosolized amikacin/fosfomycin, a Phase 2 ready, proprietary combination antibiotic, which has demonstrated potent and broad-spectrum antibacterial activity against highly drug resistant pathogens. Savara’s management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.

GrayMatter Robotics specializes in advanced robotic solutions for high-mix manufacturers facing complex surface treatment challenges. Their proprietary AI-driven robots assist humans in ergonomically demanding tasks, enhancing efficiency and productivity.

Disc Medicine is a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with severe hematologic disorders. Its pipeline includes therapies targeting erythropoietic porphyrias, Diamond-Blackfan Anemia, anemia of myelofibrosis and chronic kidney disease, as well as polycythemia vera.

CARGO Therapeutics is a clinical-stage biotechnology company developing next-generation CAR T-cell therapies to overcome cancer treatment resistance and access barriers. The company focuses on addressing limitations of approved autologous CAR T therapies, including manufacturing constraints, long turnaround times, and reimbursement challenges, to broaden patient access to potentially curative treatments. Its programs aim to deliver novel solutions that improve cancer treatment outcomes and patient experience. One of its product candidates, CRG-023, is a tri-specific CAR T designed to overcome relapse by targeting multiple B-cell antigens (CD19, CD20, CD22) and addressing mechanisms such as antigen loss, insufficient co-stimulation, and T cell exhaustion.

Scale AI develops a platform that provides training and validation data for artificial intelligence applications. Its products include advanced annotation tools for images, videos, text, documents, and 3D sensor data, serving sectors such as autonomous vehicles, retail, conversational AI, robotics, AR/VR, and document processing.

Bluejay Therapeutics is a private biopharmaceutical company focused on developing curative treatments for infectious and liver diseases. Its initial program targets chronic hepatitis B, a widespread infection with unmet medical need, using two approaches: fully human IgG1 monoclonal antibodies against hepatitis B surface antigen and oral small-molecule inhibitors of HBsAg. The aim is to reduce viral surface antigen and restore adaptive immunity, potentially achieving a functional cure for HBV and enabling patients to regain immune control of infection. The company’s work also contemplates extending its approach to other viral liver diseases, including chronic hepatitis D.

Zenas BioPharma is a clinical-stage biopharmaceutical company headquartered in Florida, USA, that specializes in developing immune-based therapies for patients. The company’s lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to target both CD19 and FcγRIIb, which are found in B cell lineages. This innovative approach aims to inhibit the activity of cells involved in various autoimmune diseases while preserving their presence, thus avoiding depletion. Through its focus on these advanced therapies, Zenas BioPharma seeks to address unmet medical needs in the treatment of autoimmune conditions.

Wiz, Inc. is a cybersecurity company founded in 2020, with headquarters in Palo Alto, California, and an additional office in Tel Aviv, Israel. The company specializes in cloud security, providing enterprises with a platform that enables them to identify security issues within their public cloud infrastructure. Wiz's innovative solution offers a comprehensive, cloud-native visibility tool that analyzes the entire cloud environment, delivering a 360-degree view of security risks across various platforms, including clouds, containers, and workloads. The platform utilizes actionable, graph-based analysis to facilitate in-depth risk assessment and root cause analysis without the need for agents, allowing organizations to enhance their security posture effectively.

BridgeBio Oncology Therapeutics is a biopharmaceutical company specializing in the development of precision oncology therapeutics. It focuses on targeting RAS-dependent cancers, leveraging a profound understanding of RAS signaling biology to create drugs that selectively inhibit RAS-driven PI3K activation and a wide spectrum of KRAS mutants. The company aims to provide patients with tailored treatments that address both active and inactive cancer-driving states.

Finvero, founded in January 2021 in Mexico City, operates a credit marketplace that connects merchants with lenders. It enables businesses to offer personalized financing options to their customers, facilitating tasks such as registering businesses and managing various credit products. This platform aims to boost average ticket sales for merchants by providing convenient credit payment solutions.

Asher Biotherapeutics, Inc. is a biotechnology company based in South San Francisco, California, founded in 2019. The company specializes in the development of immunotherapy drugs aimed at effectively treating cancer. Its innovative therapies are designed to enhance the immune system's ability to target and eliminate cancer cells while minimizing side effects. This focus allows healthcare providers to deliver effective treatments to patients in a shorter timeframe, aiming to improve overall outcomes in cancer care.

Founded in 2015 and based in Cambridge, Massachusetts, Obsidian Therapeutics develops next-generation controllable cell and gene therapies designed to extend adoptive immunotherapy to every cancer patient. Its innovative approach uses pharmacologic operating systems to precisely control protein activity in cells, enabling physicians to improve upon current cell therapies using simple, safe, orally-active marketed drugs.

Avidity Biosciences is a biopharmaceutical company developing antibody oligonucleotide conjugates to enable tissue-selective delivery and precision RNA therapies for serious diseases. Its AOC platform combines monoclonal antibody tissue targeting with oligonucleotide therapies to access previously undruggable tissues and genetic drivers. The lead candidate, AOC 1001, targets myotonic dystrophy type 1, and its muscle programs address muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and Pompe disease. The pipeline also includes immune and other cell-type programs, including Del-zota for DMD, Del-desiran for DM1, and Del-brax for FSHD. Avidity is based in La Jolla, California.

AssetWatch specializes in proactive predictive maintenance solutions. It offers a rapidly deployable remote condition monitoring service featuring wireless sensors, communication hubs, advanced software, and expert analysis. The company combines predictive analytics with expert insights to provide actionable recommendations, helping global manufacturers minimize unplanned downtime and transition from reactive to proactive maintenance.

Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.

Maza is a mobile application offering digital banking services and financial products. It provides users with access to savings accounts, NFC-enabled prepaid cards for online or offline purchases, bill payments, and money transfers, aiming to deliver a seamless and cost-effective banking experience.

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Tabby offers flexible payment solutions for online shopping. Based in the United Arab Emirates, it enables users to pay for purchases in deferred single payments or installments.

Avalyn Pharma is a biopharmaceutical company focused on developing therapies for severe respiratory diseases, notably idiopathic pulmonary fibrosis (IPF). Established in 2011, the company is headquartered in Seattle, Washington.

Fore Biotherapeutics is a precision oncology company focused on developing targeted cancer therapies guided by functional genomics. It aims to create a pipeline of treatments for patients with currently unaddressed mutations across established oncology targets.

Trove is a technology company that uses artificial intelligence to strengthen professional networks and enable sustainable retail. Its AI-powered email management tool analyzes team connections to map networks, surface relationship insights, and prioritize communications, helping users manage inbox overload and reveal potential introductions. The company also operates a resale platform for brands and retailers, offering tools to launch, manage, and scale resale programs across channels. The platform provides storefront design, photography, authentication, trade-ins, returns processing, non-new inventory management, and Shopify integration, supported by analytics that optimize pricing and merchandising for millions of items. By advancing circular commerce, Trove helps brands reach new customers, increase profits, and reduce environmental impact while maintaining operational efficiency. The company serves enterprises seeking to improve collaboration and network visibility through AI-enabled software, with a focus on sustainability and scalable growth.

Skims is a brand specializing in underwear, loungewear, and shapewear designed to enhance and complement various body shapes. They offer a wide range of products including bodysuits, shapewear, and underwear in diverse styles and colors to provide women with optimal support and coverage.

Musinsa Co., Ltd. is a fashion-focused company based in Seoul, South Korea, established in 2012. It operates both online and offline, offering a diverse range of products that include apparel, footwear, accessories, cosmetics, and more. Musinsa serves as a platform for various brands, including subculture, national, and global sports brands, providing customers with curated content, styling pictorials, and information on fashion trends. The company emphasizes customer engagement by allowing users to interact with brands and access personalized curation and storytelling. Additionally, Musinsa publishes an online fashion web magazine that showcases product information and brand highlights, further enriching the fashion culture and consumption experience in the Korean market.

Orennia is a provider of commercial analytics focused on the renewable and zero-carbon energy sectors. The company offers a platform that aggregates and cleanses extensive data related to commercial, engineering, pricing, transmission facilities, and demand. By leveraging advanced technology and insights from seasoned industry experts, Orennia aims to assist investors in making informed capital allocation decisions, ultimately accelerating their time-to-value in the renewable power sector. The company's objective insights enable clients to navigate investment opportunities effectively and with confidence in this rapidly evolving market.

Caraway is a digital healthcare company focused on providing integrated mental, reproductive, and physical healthcare services specifically for college women. Designed with input from students, Caraway delivers a personalized and equitable care solution that addresses the unique needs and concerns of women during a crucial developmental period. The platform emphasizes accessible and compassionate healthcare, recognizing the growing demand for mental health resources and the persistent inequities in women's health. By offering trusted and holistic care, Caraway empowers college students to effectively manage their health in a complex and often challenging healthcare landscape.

Upstream Bio is a clinical-stage biotechnology company focused on developing antibody therapies for severe respiratory disorders. Its lead product, Verekitug, targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine involved in inflammatory responses.

Alkeus Pharmaceuticals is a clinical-stage biopharmaceutical company based in Boston that specializes in developing treatments for serious ophthalmic conditions. The company's primary focus is on addressing untreatable diseases of the eye, with its lead drug candidate being an orally delivered compound aimed at treating Stargardt disease and age-related macular degeneration. Through its innovative approach, Alkeus aims to empower medical professionals to manage symptoms of irreversible vision loss at an earlier stage in affected patients.

EVgo operates a nationwide public and private direct-current fast-charging network for electric vehicles. Its chargers support all EV models that accept DC fast charging and can deliver up to 90 miles of range in about 30 minutes. The network serves both consumer and business customers and partners with grocery chains, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy charging infrastructure.

Boundless Bio develops innovative cancer therapeutics focused on understanding and treating previously untreatable cancers. It specializes in targeting extrachromosomal DNA (ecDNA) biology, a key driver of aggressive cancers.

Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Clerkie is an AI-driven financial planning company that focuses on helping individuals manage their debt more effectively. It offers a proprietary financial automation platform that leverages conversational AI to create detailed financial knowledge graphs. This technology enables users to receive personalized answers and actionable plans tailored to their financial situations. By combining expert financial advice with automated processes, Clerkie aims to simplify the management of debt for its users, making it easier for them to take proactive steps towards alleviating their financial burdens. The platform serves both consumers seeking financial guidance and creditors looking to manage loan losses effectively.

Saluda Medical is a medical device company specializing in closed-loop neuromodulation therapies for chronic neurological conditions. Founded in 2010 and headquartered in Australia, the company develops innovative devices like Evoke, designed to optimize neural stimulation based on real-time feedback.

HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.

Span develops intelligent hardware and software solutions that transform traditional electrical panels into modern smart hubs. Their AI-powered system enables homeowners to optimize energy usage, reduce bills, and future-proof their homes for growing energy demands.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

CARGO Therapeutics is a clinical-stage biotechnology company developing next-generation CAR T-cell therapies to overcome cancer treatment resistance and access barriers. The company focuses on addressing limitations of approved autologous CAR T therapies, including manufacturing constraints, long turnaround times, and reimbursement challenges, to broaden patient access to potentially curative treatments. Its programs aim to deliver novel solutions that improve cancer treatment outcomes and patient experience. One of its product candidates, CRG-023, is a tri-specific CAR T designed to overcome relapse by targeting multiple B-cell antigens (CD19, CD20, CD22) and addressing mechanisms such as antigen loss, insufficient co-stimulation, and T cell exhaustion.

Dataiku develops a centralized data platform that empowers businesses to navigate their data journey, from analytics at scale to enterprise AI. Its platform fosters collaboration among data experts and explorers, providing a repository of best practices, streamlined machine learning deployment, and a controlled environment. Established in 2013, Dataiku is headquartered in New York with offices in Paris and London.

Apogee Therapeutics is a San Francisco-based biotechnology company founded in 2022, specializing in the development of novel therapies for immunological and inflammatory disorders. The company focuses on creating differentiated biologics to treat conditions such as atopic dermatitis and chronic obstructive pulmonary disease, addressing significant unmet medical needs. Apogee's approach involves advancing antibody programs designed to target established mechanisms of action while utilizing advanced engineering techniques to enhance the therapeutic properties, including extended half-life. The company is actively developing two main programs: APG777 for atopic dermatitis and APG808 for chronic obstructive pulmonary disease.

Rokt is a software company that provides e-commerce technology and marketing solutions designed to weave native advertising into shoppers' transactional flows. By connecting advertisers with customers at the moment of purchase, it places relevant messages within checkout and related steps, helping e-commerce operators increase revenue, improve the customer experience, and support cross-selling and upsell opportunities.

MBX Biosciences is a biotechnology company focused on developing therapies for endocrine and metabolic disorders, emphasizing rare endocrine diseases with limited treatment options. It pursues discovery, development, and commercialization of first-in-class peptide therapeutics that modulate glandular hormone signaling. MBX has developed a proprietary Precision Endocrine Peptide platform to engineer peptides with extended time-action profiles and consistent drug exposure, aiming to overcome limitations of traditional peptide therapies and improve disease management. Based in Carmel, Indiana, the company advances novel peptide programs through clinical development to address unmet medical needs in endocrine and metabolic disorders.

Zenas BioPharma is a clinical-stage biopharmaceutical company headquartered in Florida, USA, that specializes in developing immune-based therapies for patients. The company’s lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to target both CD19 and FcγRIIb, which are found in B cell lineages. This innovative approach aims to inhibit the activity of cells involved in various autoimmune diseases while preserving their presence, thus avoiding depletion. Through its focus on these advanced therapies, Zenas BioPharma seeks to address unmet medical needs in the treatment of autoimmune conditions.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

RayzeBio, Inc. is a biotechnology company based in San Diego, California, founded in 2020. The company specializes in developing tumor-targeted small molecule medicines that leverage radioisotopes to improve cancer treatment outcomes. RayzeBio focuses on creating innovative radiopharmaceuticals, particularly utilizing alpha-emitting radioisotopes like Actinium-225, to target solid tumors effectively. With a robust pipeline of drug candidates, RayzeBio is committed to addressing significant market opportunities in oncology through late-stage clinical programs, development initiatives, and discovery efforts. The company's mission is to provide effective therapeutic solutions aimed at defeating cancer.

Flavrs is an online food discovery platform founded in 2020, headquartered in San Francisco. It combines premium food content with commerce, allowing users to watch recipe tutorials from renowned chefs and shop for ingredients via Instacart integration.

Founded in 2009, SeatGeek operates a mobile ticketing marketplace and search engine for live sports, concerts, and theater events. It aggregates ticket listings from various sources, offering users a 'Deal Score' metric to assess ticket value. The platform also provides event discovery tools based on user preferences. SeatGeek is headquartered in New York with additional offices globally.

Meati Foods produces and sells fungi-based meat alternatives. Founded in 2016, the company uses proprietary clean technologies to create nutrient-dense, plant-based products that are free from common allergens.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

FalconX, Ltd. is a cryptocurrency brokerage and digital asset trading platform founded in 2018 and based in San Mateo, California. The company specializes in blockchain technology and fintech, offering clients access to cryptocurrency markets for trading, credit, and clearing. FalconX utilizes data science and machine learning to ensure reliable execution of mid-to-large size trades, smart routing prices across multiple liquidity sources. This approach helps eliminate slippage and hidden fees, making it an attractive option for hedge funds, proprietary trading firms, and other institutional clients seeking efficient and cost-effective trading solutions.

Kinside is a Pasadena, California-based childcare platform founded in 2018 that connects working parents with a nationwide network of daycares and preschools. The platform enables families to secure care, pay for services online, and access employer-provided tax savings and contributions related to childcare. Operating as a dual-sided marketplace, Kinside partners with daycares and preschools across the United States to surface current openings, offering a transparent and affordable path for parents to find and obtain childcare.

Guild Education provides a technology platform that connects working adults with online classes, programs, and degree options, offering personalized advising and retention coaching. The service enables employers to give employees education benefits and tuition reimbursement, helping them advance their careers while the platform supports discovery, learning, and organization of the experience. It bridges the gap between education and employment, delivering a comprehensive learning journey from start to finish.

Arcadia, Inc. is a technology company based in Washington, D.C., founded in 2014, that focuses on providing access to clean energy solutions. Through its platform, Arc, the company connects subscribers to renewable energy sources such as wind farms and community solar projects. By enabling users to manage their accounts, track energy usage, and participate in clean energy initiatives, Arcadia aims to democratize access to renewable energy and combat the fossil fuel monopoly. The platform aggregates energy data from over 125 utilities, representing more than 80% of U.S. electric utility accounts, thus facilitating a significant shift toward sustainable energy practices. Additionally, Arcadia's community solar program addresses energy injustice while promoting economic growth, contributing over five Terawatt-hours of energy demand from residential and commercial users.

Span develops intelligent hardware and software solutions that transform traditional electrical panels into modern smart hubs. Their AI-powered system enables homeowners to optimize energy usage, reduce bills, and future-proof their homes for growing energy demands.

Omada Health is a digital healthcare company that offers personalized programs to manage chronic conditions such as prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health. It combines professional coaching, connected devices, real-time data, and personalized feedback to deliver clinically meaningful results.

Somatus, Inc. is a healthcare company focused on providing specialized kidney care services aimed at delaying or preventing the progression of chronic kidney disease. Founded in 2016 and headquartered in McLean, Virginia, Somatus collaborates with health plans, health systems, nephrology, and primary care groups to deliver integrated care for patients with or at risk of kidney disease. Its comprehensive services include home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplant, and conservative care. By utilizing vertically integrated clinical services and technology, Somatus seeks to improve patient outcomes, enhance care coordination, and promote the use of home dialysis modalities while increasing the rates of kidney transplantation. The company's mission is to ensure that patients can access the care they need to manage kidney disease effectively.

Synthego is a biotechnology company specializing in genome engineering. It offers integrated hardware, software, bioinformatics, chemistries, and molecular biology platforms to advance basic research and therapeutic development. Its products include engineered cells, CRISPR kits, and bioinformatics tools for gene knockout, target validation, and disease modeling. Synthego serves scientists globally, with sales through distributors in multiple countries and online.

Creditas is a financial technology company that operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

CodeSee is a developer of cloud-based data visualization software aimed at enhancing code comprehension for developers and development teams. Founded in 2019 and based in San Francisco, California, the company provides tools that facilitate a continuous understanding of the codebase throughout the development process. Its software enables users to visualize how various elements of code and functionality are interconnected, thereby improving the overall workflow and efficiency of software development.

Go Digit General Insurance Limited is a Bengaluru-based insurance provider that utilizes a digital platform to offer a wide range of insurance products. Founded in 2016 and formerly known as Oben General Insurance Limited, the company provides services including car, travel, home, commercial vehicle, shop, bike, health, and mobile insurance, as well as group health and flight delay insurance. Go Digit General Insurance is known for its customer-centric approach, focusing on claims processing, renewals, and garage services. The company generates most of its revenue from motor insurance products, catering primarily to the Indian market. As a subsidiary of Go Digit Infoworks Services Private Limited, it aims to innovate in product design and pricing strategies.

Founded in 2015, Dave is a fintech company based in Los Angeles, California. It operates a mobile application that provides users with banking services, including overdraft protection, early access to paychecks, and credit building tools. The app aims to improve financial wellness by offering transparent, fee-free banking and has grown to serve over 12 million members since its inception.

Taqanal Energy develops an energy asset orchestration platform and intelligent energy storage management system designed to optimize battery storage and related assets. The platform integrates embedded battery intelligence with cloud applications and provides APIs for assets, battery swapping and charging stations, and renewable energy resources to help businesses improve asset management and operational efficiency.

Rokt is a software company that provides e-commerce technology and marketing solutions designed to weave native advertising into shoppers' transactional flows. By connecting advertisers with customers at the moment of purchase, it places relevant messages within checkout and related steps, helping e-commerce operators increase revenue, improve the customer experience, and support cross-selling and upsell opportunities.

Anchorage Digital is a regulated crypto platform that provides institutions with integrated custody, trading, staking, governance, and regulatory-compliance infrastructure for digital asset programs. Founded in 2017 and headquartered in San Francisco, it serves institutional clients globally with a secure, compliant framework and services designed to simplify oversight and asset management.

Juspay Technologies Pvt Ltd. is a Bengaluru-based company, founded in 2012, that specializes in mobile payment solutions. It offers a suite of products, including JUSPAY SAFE, a mobile payments browser, and EXPRESS CHECKOUT, which enhances payment gateway performance. The company's online platform serves as a software-as-a-service layer over existing payment gateways, streamlining integration and improving the management of various payment options. This enables users to conduct electronic transactions securely and efficiently, catering to the evolving needs of mobile-based payments.

Olist is a Brazilian e-commerce platform that enables small and medium-sized sellers to reach online marketplaces and customers. Based in Curitiba, it connects merchants with major online retailers and provides an integrated suite of offerings across commerce, logistics, and capital, including tools to sell on marketplaces, social-commerce storefronts, a cloud-based logistics network, and financing or payment options. The company began by linking merchants to marketplaces and has evolved into a comprehensive end-to-end solution designed to help SMBs navigate a fragmented digital ecosystem and expand their reach to international marketplaces.

Learneo brands and platforms are pioneering advances in a wide range of applications for emergent technologies, including the use of AI to improve people's writing, reading and math skills, in school, professional and daily life. The platform of businesses includes CliffsNotes, the original and iconic study guide company; Course Hero, an online learning platform of academic resources; LitCharts, a creator of literature resources; QuillBot, an AI-powered writing companion helping anyone improve their writing skills; Scribbr, a multilingual academic proofreading service, and Symbolab, an AI-based mathematics resource. Learneo was established in Redwood City, California by Andrew Grauer and Gregor Carrigan.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Faire is a two-sided marketplace connecting local retail stores with unique wholesale merchandise from brands and makers. It offers retailers tools for data insights, financial terms, and logistics support to compete with larger competitors. Faire's platform simplifies wholesale buying and selling processes, offering net 60 payment terms and free returns.